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ABSTRACT
ETS-domain transcription factors play important
roles in controlling gene expression in a variety of
different contexts; however, these proteins bind
to very similar sites and it is unclear how in vivo
specificity is achieved. In silico analysis is unlikely
to reveal specific targets for individual family
members and direct experimental approaches are
therefore required. Here, we take advantage of an
inducible dominant-negative expression system
to identify a group of novel target genes for the
ETS-domain transcription factor Elk-1. Elk-1 is
thought to mainly function through cooperation
with a second transcription factor SRF, but the
targets we identify are largely SRF-independent.
Furthermore, we demonstrate that there is a high
degree of overlapping, cell type-specific, target
gene binding by Elk-1 and other ETS-domain tran-
scription factors. Our results are therefore consis-
tent with the notion that there is a high degree of
functional redundancy in target gene regulation by
ETS-domain transcription factors in addition to the
specific target gene regulation that can be dictated
through heterotypic interactions exemplified by the
Elk-1-SRF complex.
INTRODUCTION
Eukaryotic transcription factors are classiﬁed into families
based on the identity of their DNA-binding domains.
In many cases, the shared structure of the DNA binding
domain oﬀers limited opportunity for providing unique
DNA binding speciﬁcities to individual family members,
and hence a substantial overlap in DNA sequences
recognised is apparent. It is currently not fully clear how
this lack of sequence selectivity impacts on target gene
selection in vivo, but interactions with other transcription
factors in deﬁned modules are thought to provide the
driving force for generating speciﬁc promoter recognition.
The ETS-domain transcription factor family provides a
good example of these phenomena (1,2).
There are 27 known members of the ETS-domain tran-
scription factor family known in human cells (1,2). A large
number of these are actually co-expressed in any given
cell type (3). All of these proteins bind to a sequence
containing a core GGAA/T motif that is embedded in a
longer 10bp region (1,2). Subtle diﬀerences in in vitro site
selectivity are observed for individual family members, but
it is not known how this impacts on DNA binding in vivo.
In some cases, heterologous transcription factor partner
proteins have been identiﬁed that, along with an ETS-
domain protein, form a module that binds to composite
elements and hence provides further binding speciﬁcity.
The ternary complex factor (TCF) subfamily of ETS-
domain proteins represent important exemplars of this
type of action and are commonly found to bind promoters
in a complex with SRF (4–6). Elk-1, SAP-1 and SAP-2/
Net, comprise the TCF subfamily of ETS-domain tran-
scription factors and they are characterized by the
presence of a short protein interaction motif known as
the B-box, which enables them to interact cooperatively
with a second transcription factor SRF (7–9). This
protein–protein interaction with SRF apparently permits
less stringent DNA binding requirements on the TCF
partner (10). However, despite this emerging paradigm,
there are several instances where TCF binding occurs in
the absence of obvious SRF binding to the same promoter
(e.g. PAI-1; 11,12). While interaction with SRF appears to
be a property unique to the TCF subclass, it is unclear
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the absence of SRF, and whether other ETS-domain
proteins can potentially substitute for the TCFs in this
context. Indeed, a recent ChIP-chip study revealed an
apparent high degree of redundancy in promoter binding
amongst the ETS-domain transcription factors, Ets-1,
GABPa and Elf-1 in Jurkat cells (13). However, in the
same study, it was concluded that no redundancy of
promoter binding occurs with the TCF protein Elk-1,
thereby suggesting that Elk-1 has a unique repertoire
of target genes, potentially dictated by its interaction
with SRF.
To begin to investigate the target speciﬁcity of Elk-1, we
set out to identify more target genes due to the small
number of known targets. Elk-1 exhibits overlapping
in vitro DNA binding speciﬁcities with other ETS-
domain proteins (14) and moreover, also shares the
ability to interact with SRF with other members of the
TCF subfamily. Thus, to circumvent the possibility of
redundancy of function with other TCFs in particular,
we used a dominant-negative approach to identify new
genes regulated by Elk-1. Microarray analysis revealed a
number of potential Elk-1 target genes and we focussed on
one particular group that was consistently down-regulated
by a constitutively repressive form of Elk-1, Elk-1-En,
under a variety of conditions. These were veriﬁed as
direct Elk-1 targets and shown largely not to be targets
of its partner protein SRF. Furthermore, by knockdown
approaches, we show latent redundancy of ETS-domain
protein binding. This is further emphasised by the obser-
vation that other ETS-domain transcription factors can
bind the same sites in diﬀerent cell types. Our data there-
fore reveal that Elk-1 can function more widely in an
SRF-independent manner, but that this function is
highly redundant with other ETS-domain transcription
factors.
MATERIALS AND METHODS
Plasmid constructs
The following plasmids were used in mammalian cell
transfections. pSRE-Luc (pAS821) contains two copies
of the c-fos SRE (nucleotides  357 to  275, containing
both an SRF binding site and an adjacent ets motif)
upstream of a minimal tk promoter and the luciferase
gene (15). The MCL-1, BCL10, FTSJ2, SASS6,
FLJ14803, PSMD8 and MYC-driven luciferase reporter
vectors were generated by SwitchGear Genomics, and
contain  1kb of promoter fragment cloned into the
pGL3 vector (Promega). The luciferase reporter vector
(pAS2351) containing the SAS10 promoter was
produced by ligating a PCR product into pGL3 vector
using SacI/HindIII sites. The following primers were
used for PCR: (ADS1615) GCCGAGCTCAGCAACGT
ATCAAAAGTTCAG, (ADS1616) CTCAAGCTTG
GCTCACAATCTCAGGTTTTAC. pAS1407 is a
pcDNA3.1-derived plasmid encoding full length Elk-1
fused to the Engrailed repression domain and Flag
epitope {Elk-En} (16); pAS348 is a Rous sarcoma
virus (RSV) promoter-driven vector, encoding full-length
wild-type human Elk-1 fused to residues 410–490 of VP16
{Elk-VP16} (17); pMLV-SRF-VP16 encodes full-length
SRF fused to the VP16 activation domain (kindly
provided by Richard Treisman), and pRL encoding
Renilla luciferase (Promega) was used to monitor
transfection eﬃciency.
Tissue culture, cell transfection, reporter gene assays,
RT–PCR and RNA interference
EcR293(Elk-En)#1.3 (16,18), HEK 293T and HeLa cells
were grown in DMEM supplemented with 10% fetal
bovine serum, SH-Sy5y cells were grown in DMEM/F12
(1:1) medium supplemented with 10% FBS, and U937
cells were grown in RPMI 1640, with 10% serum.
Transfections were performed with polyethylenimine
(PEI) (Polysciences) for HEK 293T cells or Amaxa
Nucleofector system for U937 cells according to the
manufacturers’ instructions.
To induce, diﬀerentiation, U937 cells were treated with
50nM PMA for 3h and then grown in DMEM and 10%
FBS for up to 72h to allow diﬀerentiation.
For reporter gene assays, typically 0.2mg of reporter
plasmid and 50ng of pRL were co-transfected with
0.005–0.1mg of expression plasmids. Cell extracts were
prepared and luciferase activity was measured 24h after
transfection using the Dual-Luciferase Reporter Assay
System (Promega) according to the supplier’s protocol.
Real-time RT–PCR was carried out as described
previously (19). The following primer-pairs were used for
RT–PCR experiments. ELK1, ADS2113(50-GGTGGTGA
ATTCAAGCTGGT-30) and ADS2114 (50-ATTTGGCAT
GGTGGAGGTAA-30), MCL1, ADS2221 (50-AGACCTT
ACGACGGGTTGG-30) and ADS2222 (50-ATGGTTCG
ATGCAGCTTTCT-30);FOS,ADS4029 (50-AGAATCCG
AAGGGAAAGGAA-30) and ADS4030 (50-CTTCTCCT
TCAGCAGGTTGG-30); CHERP, ADS1609 (50-TCGG
AGGCGAATTCTACAGT-30) and ADS1610 (50-AGGT
TCCACTGGCTCTGCT-30); SAS10 ADS1611 (50-GTC
AACAGGAGGCAGAGGAG-30) and ADS1612 (50-GG
TGATTCCTTTCGCAACAT-30); ZNF410, ADS1613
(50-CCGGAGTTTTTGTCCACTTC-30) and ADS1614
(50-AAACTGTCATGGGCCAACTC-30); BCL10,
ADS1903 (50-CCTCACTGAAGTGAAGAAGG-30) and
ADS1904 (50-ATAGATTCAACAAGGGTGTCCA-30);
SAP-1, ADS2276 (50-TCGCAAGAACAAGCCTAA
CA-30) and ADS2277 (50-CTTTCCCTCCATTCTCCA
CA-30) and 18S internal control, ADS4005 (50-TCAAGA
ACGAAAGTCGGAGGTT-30) and ADS4006, (50-GGAC
ATCTAAGGGCATCACAG-30).
siRNAs against Elk-1, SAP-1, FLI-1 and matched
GAPDH control, were constructed by the Silencer
TM
siRNA construction kit (Ambion). Human Elk-1 target
sequences were: 50-AAGGCAAUGGCCACAUCAUC
U-30 (ADS 1926/1927) and 50-AAUUCAAGCUGGUG
GAUGCAG-30 (ADS 1928/1929), the SAP-1 target
sequence was 50-AAGUAAAUAAUUCAUCAAGAU-30
(ADS 1934/1935), and FLI-1 target sequences were 50-AA
GUUCACUGCUGGCCUAUAA (ADS1930/1931) and
50-AACGUCAAGCGGGAGUAUGAC-30 (ADS1932/
1933). The siRNAs against SRF and matched control
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out RNA interference (RNAi) for HeLa cells, a two-step
transfection protocol was performed in 12-well plates as
described previously (19). U937 cells were transfected
using an Amaxa Nucleofector system with 2.25mM
(3mg) of siRNA. For transfections with siRNA constructs
against Elk-1 or FLI-1, a mixture of two diﬀerent target-
ing constructs was used.
Western blot analysis
Western blotting was carried out with the primary
antibodies; Elk-1 (Epitomics), phospho-Elk-1(Ser383)
(Cell Signalling), phospho-ERK-1 and -2 (Cell
Signalling), SRF (Santa Cruz), Fli-1 (Santa Cruz), Actin
(Abcam), GAPDH (Abcam) essentially as described
previously (19).
For PMA stimulation, HeLa cells or SH-Sy5y cells were
serum starved for 24h and then treated with 10nM PMA
for indicated times. Cells were collected, lysed in cell lysis
buﬀer (Tropix) with phosphatase inhibitors (10mM
NaF, 10mM b-glycerol phosphate, 1mM Na3VO4) and
subjected to immunoblotting.
ChIP assays
Chromatin immunoprecipitation (ChIP) assays using
control IgG (Upstate) or antisera speciﬁc to Elk-1
(Epitomics), SAP-1 (Santa Cruz), SRF (Santa Cruz) and
Fli-1 (Santa Cruz) were performed as described previously
(20) except that cross-linking for U937 cells was per-
formed for 15 rather than the standard 10min. Bound
promoters were detected by PCR using primers for the
human CHERP, FTSJ2, ZNF410, SAS10, LSR68,
MOAP-1, promoters (primers listed in Supplementary
Table S8), respectively or for the c-FOS promoter or
SRF intron 3 as described previously (21).
Quantitative PCR was performed at least in duplicate,
from at least two independent experiments, using
Quantitect SYBR green PCR reagent (Qiagen) and a
Rotorgene 3000 machine (Corbett Research). Results
were analysed with Rotorgene 6.0 software (Corbett
Research) relative to input using the standard curve
method.
Microarray and bioinformatics analysis
The dominant-negative expression experiments were per-
formed in four independent batches each containing the
six samples (starved, EGF 15min and EGF 30 mins, each
with or without ponasterone A [PonA]). RNA quality was
checked using the RNA 6000 Nano Assay, and analysed
on an Agilent 2100 Bioanalyser (Agilent Technologies).
RNA was quantiﬁed using a Nanodrop ultra-low-
volume spectrophotometer (Nanodrop Technologies).
Aﬀymetrix human genome U133A microarrays were
used as described previously (16). The technical quality
control of array data was performed with dChip (V2005)
using the default settings (www.dchip.org; 22). Back-
ground correction and quantile normalization were
performed using RMA in Bioconductor (23) using an
Aﬀymetrix Chip Deﬁnition (CDF) from AﬀyProbeMiner
gene consistent ccds 1.8.0 distribution (AﬀyProbeMiner: a
web resource for computing or retrieving accurately
redeﬁned Aﬀymetrix probe sets; 24). Since a Principal
Components Analysis showed a strong batch eﬀect,
a batch removal step was performed with Partek
Genomics Solution (version 6.3, Copyright 2005, Partek
Inc., St Charles, MO, USA). Expression values were then
analysed for diﬀerential expression due to ponA exposure
in three separate two-way analyses (starved, EGF 15min
and EGF 30min) using Cyber-T (25). The mean of expres-
sion changes for each probeset under each condition was
then calculated and a gene list of 877 diﬀerentially
expressed genes was created by ﬁltering for probesets
with (i) a P<0.05 in any of the three tests of starved,
EGF 15min or EGF 30min (ii) fold change less than 1
(natural number scale, since we were only interested
in genes down-regulated by dominant negative Elk-1).
This gene list was segregated into eight clusters based on
similarity of expression proﬁle across the dataset using a
K-means clustering algorithm. Clustering was performed
on the means of each sample group (log 2) that had
been z-transformed [for each probeset across all six
conditions, the mean was set to zero, standard deviation
to 1). K-means clustering was done on the basis of simi-
larity of proﬁles across the dataset using the ‘Super
Grouper’ plugin of maxdView software (available from
http://bioinf.man.ac.uk/microarray/maxd/)]. The similar-
ity metric used to quantify the similarity between two
proﬁles was ‘Slope’.
In each of the eight gene clusters, Aﬀymetrix probe
identiﬁers were converted into Ensembl (version 49;
http://www.ensembl.org; 26) gene identiﬁers, using the
Clone/GeneID converter (http://idconverter.bioinfo.cnio
.es; 27). Aﬀymetrix probe sets associated with more than
one Ensembl identiﬁer were rejected, resulting in an
unambiguous set of genes corresponding to each expres-
sion result from the microarray experiment. The Ensembl
data mining tool Biomart was used to extract the genome
coordinates of the Ensembl genes identiﬁed above. The
promoter regions were then identiﬁed as  1000bp and
+1000bp of the most 50 transcription start site, bearing
in mind the strand on which the gene resides. Genomic
sequence corresponding to the human genome (hg18/
NCBI36) was obtained using Galaxy (http://g2.trac.bx
.psu.edu; 28). The resulting sequences were repeat
masked. A set of 300 random Ensembl gene promoters
were also prepared.
Novel motif discovery within the promoter sequences
was performed using the stand-alone version of Weeder
1.3.1 (29). Searches were performed using the parameter
‘small’ (motifs of length 6 and 8), using both sequence
strands and allowing the expectation that motif may
appear more than once in a given sequence. The identiﬁ-
cation of known Elk-1 and SRF motif consensus
sequences within the promoter sequences was performed
using a PERL script. The script identiﬁed matches to
supplied IUPAC consensus sequence in the forward and
reverse strands of repeat masked sequences.
The intersect between lists of genes associated with the
eight gene clusters and the dataset containing promoters
identiﬁed as bound by Elk-1, SRF (32) or GABPa (30)
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lists’ (http://jura.wi.mit.edu/bioc/tools/compare.html).
The Z-score statistic was calculated by ﬁrst identifying
the overlap of gene symbols associated with each cluster to
a second gene list; 1000 lists of random gene symbols (each
containing an equal number of symbols to the gene cluster
that was tested) was then compared against the second
gene list. The mean and standard deviation of the percent-
age overlap of gene symbols of the 1000 comparisons
was calculated and compared to the observed mean per-
centage overlap. A two-tailed P-value of the Z-score was
calculated using the Microsoft Excel NORMSDIST
function P-value=2*(1 (NORMSDIST(Z-score))).
The functional proﬁling of genes that belong to the
eight Elk-En-regulated clusters was performed using the
DAVID bioinformatics resource 2008 (31; http://david
.abcc.ncifcrf.gov/). Gene symbol gene lists for each of
the eight clusters were uploaded into DAVID and
the ‘functional annotation tool’ was used to identify
over-represented GO terms (‘molecular function’ levels 3
and 5, plus ‘biological property’ Level 5), reporting
uncorrected P-values.
RESULTS
Identiﬁcation of genes regulated by dominant-negative
version of Elk-1
To identify genes regulated by Elk-1, we used a stable
EcR293 cell line containing a ponasterone A (PonA)-
inducible gene encoding full-length Elk-1 fused to the
engrailed repression domain (Elk-En) (Figure 1A; 16,18).
By retaining all the functional domains of Elk-1, we pre-
dicted that we would increase our chances of identifying
bona ﬁde target genes; additional domains such as the
SRF-binding B-box would potentially contribute to the
target selectivity of Elk-1. Indeed, our previous studies
demonstrated that Elk-En functioned as expected to
repress the activity of known Elk-1 target genes and
mutation of the B-box blocked the repressive activity of
Elk-En against promoters regulated by the Elk-1-SRF
module (18). The level of Elk-En expression was
roughly equivalent to that of endogenous Elk-1 found
in HeLa cells at both the mRNA and protein levels
(Supplementary Figure S1).
We compared the mRNA expression proﬁles of
EcR293(Elk-En) cells in the absence and presence of
induction of Elk-En expression by PonA treatment,
under three diﬀerent conditions; (i) in serum starved
cells (ii) in cells stimulated with EGF for 15min and
(iii) in cells stimulated with EGF for 30min (Figure 1B).
The latter two conditions result in ERK MAP kinase
pathway activation, which is a known upstream regulator
of Elk-1 activity (3,4,11). Elk-En was induced with PonA
addition for 3h prior to EGF stimulation and mRNA
isolation. Three experimental replicates were performed
under each condition. A total of 877 genes displayed
signiﬁcantly decreased expression (Supplementary Table
S1; P< 0.05) in response to Elk-En expression, under at
least one of these conditions. These genes were then
clustered according to their responses to EGF treatment
and to PonA treatment. This gave rise to eight clusters
of genes with diﬀerent response patterns (Figure 1C;
Supplementary Figure S2; Supplementary Table S1).
Genes from cluster 7 appeared to follow the expected
pattern for regulation by Elk-1: their expression is
induced in response to EGF stimulation at both 15 and
30min and down-regulated in response to induction of
Elk-En expression. Clusters 5 and 8 also show up-
regulation by EGF at both time-points but down-
regulation by Elk-En only following EGF treatment.
These clusters contain known Elk-1 target genes such as
FOS (cluster 8), EGR1 (cluster 7) and IER2 (cluster 5). In
contrast, the expression of the 77 genes in cluster 3 was
barely aﬀected by EGF treatment, although they were
consistently down-regulated by Elk-En under all
conditions analysed (Figure 1C and D). The patterns of
gene expression changes in the other clusters are not
readily explicable, and might have arisen due to indirect
eﬀects through Elk-En controlling the expression of genes
encoding other transcription factors or regulatory
molecules; for example, the early increases in gene expres-
sion due to PonA treatment in cluster 2 could arise due to
Elk-En repressing a repressor protein that controls this set
of genes. We therefore decided to focus on cluster 3 genes
as these appear to be a novel class of Elk-1 target gene:
they are consistently down-regulated by Elk-En under all
conditions and, unlike known Elk-1 target genes, do not
respond to MAPK pathway activation by EGF.
We also investigated whether any of the expression
clusters were enriched for genes belonging to a common
functional category by using the DAVID bioinformatics
resource (31). Under the stringent criteria that we set, no
GO terms were signiﬁcantly enriched in clusters 1, 2, 6 and
7. In contrast, either when combined or analysed individ-
ually, clusters 2, 4, 5 and 8 showed enrichment of a
number of functional categories (Supplementary Tables
S2 and S3). For example, cluster 3 was enriched for genes
involved in nucleotide processing/metabolism and DNA-
dependent transcription, whereas cluster 5 genes were
involved in more general biosynthetic processes, sugar
metabolism, and translation. Cluster 4 was enriched for
genes involved in cell structure, intracellular transport
and nucleotide binding. Cluster 8 genes were associated
with nucleotide biosynthesis. When considered together,
genes within clusters 2, 4, 5 and 8 showed enrichment for
a combination of these functional categories but also
revealed enrichment of genes associated with apoptosis.
Together, these results therefore reveal that the unique
expression patterns of clusters 3, 4, 5 and 8 in response to
EGFtreatmentandElk-Enexpressionalsoreﬂectpotential
co-regulation of distinct categories of target genes.
Elk-1 directly regulates cluster 3 genes
To establish whether genes in cluster 3 are directly
targeted by Elk-1, we ﬁrst carried out reporter gene
analysis using promoters derived from genes in this
cluster. Increasing amounts of Elk-En inhibited the expres-
sion of the known target genes c-FOS and MCL-1, as
observed previously (Figure 2A; 16). Similar dose-
dependent Elk-En-mediated repression of the promoters
Nucleic Acids Research, 2009,Vol.37, No. 22 7371from the cluster 3 genes SAS10 and BCL10 was observed
(Figure 2A). Importantly, this eﬀect is speciﬁc as the
SASS6, FLJ14803 and PSMD8 promoters do not
respond to Elk-En to the same extent (Supplementary
Figure S3A). Thus, Elk-En acts on cluster 3 gene
promoters to alter their transcription rates.
To determine whether Elk-1 binds to cluster 3
promoters directly at endogenous levels of Elk-1 expres-
sion we performed ChIP analysis in HeLa cells. We
included ZNF410 in this analysis as although it does not
appear in the ﬁnal cluster 3 list (due to narrowly missing
the cut-oﬀ thresholds), earlier analyses indicated that
it was consistently down-regulated by Elk-En. Direct
binding of Elk-1 was clearly observed to 5 of 6 genes
analysed (Figure 2B). The other promoter tested from
MOAP1, exhibited lower levels of binding, which might
reﬂect that either: (i) steric hindrance occurs at this
promoter; (ii) it is an indirect target; or (iii) we have
tested the wrong part of the promoter.
Further insights into direct Elk-1 target genes amongst
the genes in cluster 3 could be discerned from comparisons
to a recent ChIP-chip study in Hela cells (32). In total, 77/
877 (9%) genes showing down-regulation by Elk-En under
at least one condition, were also identiﬁed by ChIP-chip
analysis as direct Elk-1 targets (Supplementary Table 4).
Importantly though, another 15 promoters were revealed
as direct Elk-1 targets by comparing the genes in cluster 3
with promoter regions shown to be bound by Elk-1 by
ChIP-chip analysis. This overlap was highly signiﬁcant
when compared to a series of randomly generated equiv-
alent sized datasets (Figure 2C; Supplementary Tables S1
and S4). These random datasets represent the average of
1000 lists of gene symbols that contain the same number
of gene symbols as found in each cluster that was tested.
Indeed, this value represented nearly 20% of all cluster 3
genes, whereas the overlap was not as large for any of the
other clusters, with the next nearest being clusters 5
and 8 (12% overlap), and the lowest being cluster 7 (4%
overlap) (Supplementary Table S4). Importantly,
although lower in percentage terms, the overlap with
clusters 5 and 8 was still signiﬁcant (Z-scores 2.8 and
2.1, respectively).
To further investigate the nature of the promoters con-
trolling cluster 3 genes, we searched for motifs that
resembled the consensus binding motif AACCGGAAGT
that was identiﬁed for Elk-1 by in vitro site-selection
analysis (14). We searched within the proximal promoter
regions deﬁned as ±1kb from the most 50 transcriptional
A
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Figure 1. Identiﬁcation of Elk-1-regulated genes. (A) Diagrammatic
representation of the mode of action of Elk-En. Elk-En binds to ETS
motifs within promoters and represses promoter activity. (B)
Illustration of the induction regime used for sample preparation. The
expression of Elk-En is stimulated by adding ponasterone A (PonA) to
the EcR-293 (Elk-En) cells for 6h. Cells were grown in the presence or
absence of PonA, and either left serum starved or treated with EGF for
15 or 30min before harvesting. (C) Cluster analysis of 877 genes, which
show consistent downregulation upon PonA addition under at least one
of the three experimental conditions (serum starved, 15min EGF and
30min EGF). Columns 1–6 show the relative expression of the groups
of probesets representing each gene. Columns 7–9 represent the same
data but show fold change in response due to PonA treatment.
Hierarchical clustering was performed on columns 1–6. (D)
Expression proﬁles of individual genes in cluster 3. Each gene is
represented by a diﬀerent coloured line. The black squares and line
represents the average expression value of genes in this cluster under
each of the six experimental conditions. For each gene, the mean of the
probe sets across all six conditions was set as zero, and expression
levels (log2) are presented relative to this value.
7372 Nucleic Acids Research, 2009,Vol.37, No. 22start site of each gene. Using three diﬀerent overlapping
hexameric submotifs derived from the last 8 nucleotides in
this decamer, we could ﬁnd signiﬁcant over-representation
in cluster 3 gene promoters: 79–85% of all promoters
contained either CCGGAA, CGGAAG or GGAAGT
(Supplementary Table S5). Moreover, if we relaxed the
stringency to CCGGAW, CGGAWG or GGAWGT,
the incidence of these motifs rose to 85–90%. Lower
incidences of octameric representations of this binding
motif were found: either AACCGGAA, ACCGGAAG
or CCGGAAGT were found in 35% of all cluster 3
promoters, but these were substantially enriched
compared to only 11% incidence in a random dataset.
Thus, Elk-1 binding motifs are vastly over-represented in
cluster 3 gene promoters. Cluster 5, cluster 8 and to a
lesser extent cluster 4, also exhibited over-representation
of Elk-1 binding motifs (Supplementary Table S5). This is
consistent with the observation that these clusters also
contain signiﬁcant numbers of Elk-1 targets identiﬁed by
ChIP-chip analysis. As an alternative approach we used
Weeder (28) to look for over-represented motifs in each of
the clusters. Two of the three highest ranking motifs
closely resembled the Elk-1 binding motif identiﬁed by
in vitro site-selection analysis (Figure 2D) (14). Similarly
high scoring motifs that resembled ETS transcription
factor binding sites could be discerned in clusters 4, 5
and 8 (Supplementary Figure S2).
Together, these results demonstrate that a large propor-
tion of cluster 3 gene promoters represent direct Elk-1
targets and this is reﬂected by the over-representation of
Elk-1 binding motifs within these promoters. Similarly,
clusters 4, 5 and 8 exhibit some of these characteristics
and hence also likely represent direct Elk-1 targets.
SRF binding is not detectable at the majority of cluster
3 gene promoters
The established paradigm for Elk-1 function is that it
works through forming complexes with a second tran-
scription factor, SRF. However, there are a growing
number of instances where SRF-independent promoter
regulation has been documented. Since cluster 3 genes
do not respond to MAP kinase signalling in a manner
expected of an SRF-Elk-1 module, we checked whether
SRF was important in controlling these genes.
First, we analysed SRF binding by ChIP analysis.
In contrast to the high occupancy observed with Elk-1,
only one of the four genes tested in this cluster (MCL1)
had signiﬁcant SRF binding (Figure 3A). MCL1 is a
known target of the Elk-1-SRF complex (16,33). In
addition, we compared the genes identiﬁed as high
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Figure 2. Elk-1 binds to cluster 3 gene promoters. (A) Elk-En down-
regulates cluster 3 gene promoters. HEK293T cells were transiently
transfected with a luciferase construct containing the indicated
promoters and with increasing concentrations of Elk-En(WT) (0, 0.5,
5, 50ng; increasing concentrations indicated by a triangle). The results
were normalized to renilla luciferase activity, and the activity in the
absence of Elk-En given the value of one. Error bars represent
standard deviation calculated from three biologically independent
replicates, each representing the average of two samples. (B) ChIP val-
idation of Elk-1 binding to cluster 3 genes promoters. ChIP assay from
HeLa cells using Elk-1-speciﬁc antibodies or a non-speciﬁc rabbit IgG,
followed by real-time PCR. An SRF intronic region [SRF(Int3)] and
the c-FOS promoter region were used as negative and positive controls
respectively. Relative binding indicates percentage bound relative to
input. Fold enrichment of Elk-1 over IgG control precipitation is
shown above the bars. Results shown are representative of at least
two independent experiments and are the average of two samples,
and standard deviation. (C) Venn diagrams illustrating the overlap
between cluster 3 genes and Elk-1 target genes identiﬁed by ChIP-
chip analysis. As a comparison, the average overlap between the 1204
target genes associated with regions identiﬁed by ChIP-chip analysis
and 1000 randomly selected groups of 77 genes is shown. (D) Motif
logos of two of the top three sequence motifs discovered by Weeder in
cluster 3 gene promoters. The Elk-1 binding motif identiﬁed from site
selection studies (14) is shown at the bottom.
Nucleic Acids Research, 2009,Vol.37, No. 22 7373conﬁdence direct SRF targets in both HeLa (32) and
Jurkat (30) cells by ChIP-chip and ChIP-Seq analysis
respectively, to the Elk-En-regulated genes in each
cluster. A statistically signiﬁcant overlap was seen with
genes in cluster 3, but the total number of genes
involved was low (Supplementary Table S6), further
emphasising that many genes in this cluster seem to be
regulated independently from SRF. Consistent with this
small overlap, there was no evidence for over-
representation of the SRF binding motif CCW6GG
in the promoters of cluster 3 genes (Supplementary
Table S5). The ChIP-derived SRF dataset also exhibited
a small but statistically signiﬁcant overlap with genes
in clusters 5 and 8, but not with any of the other
clusters (Supplementary Table S6).
To probe potential functional regulatory links between
SRF and cluster 3 genes, we reduced SRF levels by siRNA
treatment. Knockdown of SRF resulted in little change in
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Figure 3. Role of SRF in cluster 3 gene regulation. (A) SRF binding to selected cluster 3 gene promoters. HeLa cells were serum starved for 24h,
followed by ChIP with SRF or non-speciﬁc rabbit IgG antibodies. ChIP DNA was subjected to qPCR. Relative binding indicates percentage binding
relative to input sample. The ratio between SRF and non-speciﬁc IgG is indicated above the bars. An SRF intronic region [SRF(Int3)] and the
c-FOS promoter region were used as negative and positive controls, respectively. Error bars represent standard deviation calculated from three
biologically independent replicates and the average of two samples. (B) Western blot analysis of siRNA-mediated knockdown of SRF and GAPDH.
(C) Quantitative RT–PCR analysis of cluster 3 genes upon SRF knockdown. HeLa cells were transfected with siRNA against SRF or GAPDH. Cells
were either left in serum free medium for 48h or treated with 20% FCS for 30min and mRNA levels were measured. Error bars represent standard
deviations calculated from three biologically independent replicates, each representing the average of two samples. Asterisks denote diﬀerences with
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7374 Nucleic Acids Research, 2009,Vol.37, No. 22the expression of cluster 3 genes, with the exception of
MCL1 and ZNF410 (Figure 3B and C). However, in the
latter case, this regulation is likely indirect or through a
site located outside the region tested by ChIP. We also
compared the response of several of the cluster 3
promoters to the expression of constitutively active
Elk-1 (Elk-VP16) or SRF (SRF-VP16) fusion proteins.
Elk-VP16 activated all the tested promoters in a dose-
dependent manner (Figure 3D). This eﬀect was speciﬁc
as a number of control promoters were unresponsive to
Elk-VP16 (Supplementary Figure S3B). In contrast, SRF-
VP16 activated an SRE-driven reporter, the MCL1
promoter and the BCL10 promoter in a dose-dependent
manner but failed to promote signiﬁcant activation of the
SAS10 and MYC promoters (Figure 3E). Similarly, little
activation of the FTSJ2 promoter was observed, with
only slight increases detected at the highest levels of
transfected SRF.
Collectively, these various lines of evidence demonstrate
that the Elk-1 target genes in cluster 3 are largely regulated
in an SRF-independent manner.
Redundant binding of ETS-domain proteins to cluster 3
gene promoters
To establish a potential functional role for Elk-1 in con-
trolling the activity of the genes in cluster 3, we determined
the expression levels of several of these target genes in
HeLa cells upon knockdown of Elk-1 levels by siRNA
treatment. However, depletion of Elk-1 had little eﬀect
on the activity of these target genes either in the absence
or presence of PMA (data not shown). Indeed, while the
Elk-1 target gene FOS was rapidly and potently activated
in both HeLa and SH-Sy5y cells in response to ERK
pathway activation by PMA treatment, only small
changes in the expression of the cluster 3 genes CHERP,
SAS10 and ZNF410 were observed (Supplementary
Figure S4C). Elk-1 was eﬃciently activated as revealed
by increased phosphorylation in response to PMA treat-
ment in both cell types (Supplementary Figure S4C).
One possible reason for this lack of response to Elk-1
depletion is functional redundancy, where alternative
ETS-domain transcription factors might substitute for
Elk-1. In particular, the closely related TCF subfamily
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Figure 4. Redundancy of Elk-1 and SAP-1 binding to cluster 3 promoters. (A) HeLa cells were transfected with the indicated siRNAs and Elk-1
expression monitored by western analysis (left panel) and SAP-1 expression by qRT–PCR (right panel). (B and C) qPCR-ChIP analysis of SAP-1 (B)
and Elk-1 (C) binding to the indicated promoters in HeLa cells. Where indicated, cells were transfected with siRNA against Elk-1, SAP-1 or
GAPDH. Samples from serum-starved HeLa cells taken 48h after transfection with the indicated siRNAs. ChIP was performed using antibodies
against SAP-1 (B) or Elk-1 (C) or non-speciﬁc rabbit IgG. Note that the same IgG data are presented in (B and C) as these experiments were
performed at the same time. The relative binding is the percentage binding relative to input sample. Error bars represent standard deviations
calculated from two biologically independent replicates each being the average of duplicate samples. Arrows indicate the increase of Elk-1
binding to the promoters upon SAP-1 knock-down.
Nucleic Acids Research, 2009,Vol.37, No. 22 7375member SAP-1 is a likely candidate. SAP-1 binding was
detected at the promoters of all the cluster 3 genes
analysed (Figure 4B). To establish the speciﬁcity of the
SAP-1 ChIP, we depleted SAP-1 levels in HeLa cells by
siRNA treatment, and on each target promoter,
reductions in SAP-1 binding were observed (Figure 4B).
The speciﬁc depletion of SAP-1 mRNA levels was con-
ﬁrmed by RT–PCR (Figure 4A). Next, we examined the
eﬀect of reducing SAP-1 levels on Elk-1 binding to
promoters of cluster 3 genes. As expected, siRNA-
mediated depletion of Elk-1 levels caused a reduction
in the association of Elk-1 to the tested promoters
(Figure 4C). In contrast, depletion of SAP-1 resulted in
a reciprocal increase in Elk-1 binding which was particu-
larly signiﬁcant at the CHERP and SAS10 promoters
(Figure 4C; Supplementary Figure S5). Similar eﬀects
were observed in 293T cells (data not shown). Western
analysis conﬁrmed the eﬀectiveness and speciﬁcity of
Elk-1 depletion (Figure 4A). Thus, these ﬁndings are
consistent with redundant binding of the TCFs Elk-1
and SAP-1 at cluster 3 gene promoters.
Further functional redundancy is also possible in other
cell types and where other ETS-domain transcription
factors are expressed. Indeed, this has been shown to be
the case for the ETS-domain proteins, Ets-1, Elf-1 and
GABPa: ChIP-chip analysis has suggested a high degree
of redundant promoter occupancy in Jurkat cells (13). We
therefore tested whether promoter occupancy by diﬀerent,
more divergent, ETS-proteins could be detected in
undiﬀerentiated and diﬀerentiated monocytic-like U937
cells. U937 cells express both Elk-1 and FLI-1, but the
ratio of these two ETS-domain proteins varies depending
on diﬀerentiation status. This is largely due to the larger
PMA-induced increases in Elk-1 levels that are seen as
U937 cells are stimulated to diﬀerentiate (5-fold increase
for Elk-1 compared to 3-fold for FLI-1; Figure 5A). Next,
we examined the expression of several cluster 3 target
genes in response to stimulation of U937 cells with
PMA (Figure 5B). FOS expression increased following
stimulation by PMA, which is known to activate the
ERK pathway and hence activate Elk-1 on the FOS
promoter. However, in contrast, the expression of the
cluster 3 genes CHERP, SAS10 and ZNF410 decreased
substantially after PMA stimulation (Figure 5B) suggest-
ing a non-linear relationship between Elk-1 levels and
target gene activity.
Next, we tested the promoter occupancy of several
cluster 3 genes by FLI-1 and Elk-1. ChIP analysis
demonstrated that both Elk-1 and FLI-1 bind the
promoters from CHERP and SAS10 in undiﬀerentiated
(Figure 5C) and diﬀerentiated (Figure 5D) U937 cells.
However, the relative ratios of Elk-1 and FLI-1 bound
diﬀered depending on diﬀerentiation status, with relatively
more binding seen in the diﬀerentiated cells, which is com-
mensurate with the increasing Elk-1 levels in these cells.
In contrast, Elk-1 was the major binding protein on the
FOS and MCL1 promoters in U937 cells irrespective of
diﬀerentiation status (Figure 5C and D). Together these
results demonstrate redundancy of ETS-domain protein
binding to cluster 3 gene promoters where dynamic
changes in promoter occupancy are observed during
U937 cell diﬀerentiation. Moreover, they underline the
distinctive role for Elk-1 on promoters such as FOS and
MCL1 where SRF promotes selectivity in ETS-domain
protein binding.
To probe functional links between promoter occupancy,
and transcription factor binding and promoter activation,
we examined the expression of the cluster 3 genes CHERP
and SAS10 following siRNA-mediated depletion of Elk-1
or FLI-1 in U937 cells (Figure 5E). CHERP levels were
reduced by depletion of Elk-1, which was most apparent
in undiﬀerentiated cells. In contrast depletion of FLI-1
had little eﬀect on CHERP levels. Reciprocal eﬀects
were seen on SAS10 expression, where Elk-1 depletion
had little eﬀect but FLI-1 depletion caused a marked
reduction in expression in diﬀerentiated cells. Thus,
despite the binding of both transcription factors being
detectable on both promoters in both diﬀerentiated and
undiﬀerentiated cells, there is a clear delineation in
function that can be attributed to each transcription
factor in regulating a distinct target gene under diﬀerent
cellular diﬀerentiation states.
As there is apparently a large overlap in promoter
binding by Elk-1 and FLI-1, we wondered whether other
ETS transcription factors might also occupy similar sites.
As a further test for this potential redundancy in promoter
binding, we compared the occupancy of promoters in each
of the eight gene expression clusters derived from Elk-En
induction, with the promoter binding for the divergent
ETS-domain transcription factor GABPa determined by
ChIP-Seq analysis in Jurkat cells (30) (Supplementary
Table S7). Cluster 3 gene promoters exhibited substantial
overlap with promoters occupied by GABPa (67% of
genes; P<0.0001) (Figure 5F). Clusters 4, 5 and 8 also
showed substantial overlap with GABPa binding events
(Supplementary Table S7; 43, 57 and 52%, respectively)
but the other four clusters showed essentially random
overlap with this dataset. Thus, we have identiﬁed a
number of genes that are direct Elk-1 targets but the
majority of which can also be redundantly targeted by
diﬀerent ETS-domain transcription factors.
Collectively, these results demonstrate that Elk-1 plays
a role in regulating the expression of at least a subset of
cluster 3 genes; however, a particularly characteristic
feature of cluster 3 genes is redundant promoter binding
by Elk-1 and other ETS-domain transcription factors.
This redundant binding is also exhibited amongst other
gene clusters identiﬁed as potential direct Elk-1 targets,
illustrating a more widespread redundancy in promoter
recognition by ETS transcription factors and potentially
redundancy in gene regulation.
DISCUSSION
The overlapping in vitro DNA binding speciﬁcities of
ETS-domain transcription factors suggests that either
additional mechanisms are needed for in vivo selectivity
or that they can bind to largely overlapping sets
of promoters. Previous studies on the TCF subfamily of
ETS-domain transcription factors have provided a model
whereby in vivo selectivity is largely dictated through
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Figure 5. Cluster 3 gene regulation upon monocytic U937 cell diﬀerentiation. (A) Western analysis of changes in Fli-1 and Elk-1 levels upon U937
cell diﬀerentiation following PMA treatment for the indicated times. Quantiﬁcation of the expression of each protein relative to the amount in
undiﬀerentiated cells (taken as 1) is shown below. (B) Reduced expression of cluster 3 genes upon monocyte diﬀerentiation. U937 cells were taken
either before PMA-induced diﬀerentiation or 24 or 72h after PMA addition. Expression levels of indicated genes were measured by quantitative RT–
PCR. Error bars represent standard deviations calculated from two biologically independent replicates which are the average of two samples. (C and
D) Dynamic changes in Elk-1 and Fli-1 binding to cluster 3 gene promoters upon monocyte diﬀerentiation. qPCR of ChIP DNA from
undiﬀerentiated (C) and diﬀerentiated (D) U937 cells using Elk-1 or Fli-1 speciﬁc antibodies or a non-speciﬁc total rabbit IgG (IgG).
Diﬀerentiated cells were analysed 48hrs after PMA stimulation. The relative binding is the percentage binding relative to input sample. Data are
the average of at least two independent experiments and duplicate samples,   standard deviation. (E) siRNA-mediated Elk-1 and FLI-1 depletion
and cluster 3 gene expression in U937 cells. U937 cells were transfected with 3mg of siRNA targeted against Elk-1 or FLI-1 (dark grey bars) or
GAPDH (light grey bars). Cells were left for 24h after transfection, then undiﬀerentiated cells (0h) were collected, and diﬀerentiated cells were
created by treatment with 50nM PMA for 3h and left to diﬀerentiate for another 48h. mRNA was isolated and the expression levels of indicated
genes in the presence of reduced levels of Elk-1 (left) or FLI-1 (right) was analysed using qRT–PCR. Error bars represent standard deviations
calculated from three biologically independent replicates and the average of two samples. (F) Venn diagrams illustrating the overlap between cluster 3
genes and GABPa target genes identiﬁed by ChIP-seq analysis (30). As a comparison, the average overlap between the 5091 target genes identiﬁed by
ChIP-seq analysis and 1000 randomly selected groups of 77 genes is shown.
Nucleic Acids Research, 2009,Vol.37, No. 22 7377interaction with a second transcription factor SRF (4–6).
However, here we have identiﬁed a group of Elk-1 target
genes that are occupied by Elk-1 in an SRF-independent
manner. Moreover, we demonstrate that many of these
new targets can also be bound by other ETS-domain
proteins under diﬀerent conditions, suggesting a high
degree of functional redundancy in promoter binding
amongst ETS-domain transcription factors. Thus, while
Elk-1 is speciﬁcally directed to some target genes by an
SRF-Elk-1 transcription factor core module, many other
targets bind Elk-1 independently of SRF.
Our results also extend recent observations that
demonstrated highly overlapping promoter binding
patterns between the ETS-domain transcription factors
Ets-1, Elf-1 and GABPa (13), suggesting a high degree
of functional redundancy amongst ETS-domain proteins.
Here, we add further weight to this conclusion as we show
that redundant promoter occupancy can be observed for
Elk-1 and the closely related transcription factor SAP-1,
and also between Elk-1 and the more distantly related
FLI-1. Such redundant promoter binding makes func-
tional interrogation of ETS-domain transcription factor
action diﬃcult to achieve as knockdown of one member
is likely compensated for by a diﬀerent member. This was
apparent in our study where depletion of Elk-1 levels
in HeLa cells had little eﬀect on target gene expression
(data not shown). However, in an alternative cell type
(monocytic U937 cells), we were able to see an eﬀect of
Elk-1 depletion on CHERP gene expression, indicating
that the cellular environment has a key role in dictating
the functional speciﬁcity of individual ETS-domain
proteins. Indeed, although both Elk-1 and FLI-1 were
shown to bind the SAS10 promoter, only depletion of
FLI-1 caused a reduction in SAS10 gene expression, and
this eﬀect was only observed in diﬀerentiated cells. It is
currently unclear what contributes to the ability of Elk-1
and FLI-1 to speciﬁcally regulate CHERP and SAS10
expression respectively, but diﬀerent signalling conditions
or the availability of diﬀerent partner proteins, most likely
dictates these diﬀerent functional outcomes.
The main conclusions of this study are also supported
by comparative analysis of a much larger set of Elk-1
targets identiﬁed in a recent ChIP-chip study (32).
77/877 (9 %) targets from the current study were also
identiﬁed in the highest conﬁdence data set from the
ChIP-chip analysis; within cluster 3a higher percentage
(15/77, 19%) was identiﬁed. Moreover, when a more com-
prehensive ChIP-Seq dataset for GABPa binding was
analysed, the overlap was even more striking: 333/877
(38 %) targets from the current study were also identiﬁed
in the ChIP-Seq analysis. In several clusters, the overlap
was even higher (e.g. 52/77, 68% in cluster 3). This
emphasises the quality of our dataset from the Elk-En
experiment and also further underlines the likely redun-
dancy of ETS protein binding to the promoters from these
genes.
Comparison of ChIP-chip datasets for Elk-1 and SRF
demonstrated that although co-occupancy of promoters
by SRF and Elk-1 accounted for around 22% of the
Elk-1 targets, overall co-occupancy was a rather infre-
quent event with 78% of promoters not co-bound by
SRF (32). Thus the paradigm derived from studies of
the FOS promoter, where SRF is an obligate binding
partner, appears to apply to a subset of genes rather
than, the majority of Elk-1 target genes. This ﬁnding is
further emphasized here, as we ﬁnd little evidence for a
substantial overlap in Elk-1 and SRF occupancy at target
genes. Interestingly, there are a small number of
promoters in the Elk-En target gene clusters that overlap
with a high conﬁdence SRF binding dataset created
by identifying common targets in both ChIP-Chip
(32) and ChIP-Seq (30) studies. These promoters are
predominantly in clusters 3, 4, 5 and 8 (15/16 genes),
which are the highest conﬁdence Elk-1 targets. Overall,
therefore there is an important subset of Elk-1 targets
that are also bound by SRF, further emphasizing the
importance of this transcription factor module, yet the
major mode of function of Elk-1 appears to be indepen-
dent of SRF, which then obliges Elk-1 to compete with
other ETS transcription factors for promoter occupancy.
In cases where highly redundant binding of transcrip-
tion factors occurs, such as that observed amongst the
ETS-domain family, elucidating function is diﬃcult
by conventional single protein knockdown studies.
However, the current study demonstrates a possible way
forward through using a dominant-negative type of
overexpression approach. Alternative strategies such as
introducing promoter mutations in the ETS factor
binding site are also informative but not amenable to
interrogating large numbers of potential target genes.
The use of an inducible dominant-negative type Elk-1
construct (Elk-En) coupled to expression array analysis,
enabled us to identify a high conﬁdence dataset that
represented potential targets for ETS-domain transcrip-
tion factors and subsequent clustering further ﬁltered
this dataset. Four of the clusters (3, 4, 5 and 8 comprising
459/877 {53%} Elk-En-regulated genes) represented
potential direct targets by several criteria: (i) qPCR-
ChIP demonstrated that a large number of cluster 3
genes are direct Elk-1 targets; (ii) there is a signiﬁcant
overlap in these clusters with Elk-1 direct targets identiﬁed
by ChIP-chip (Supplementary Table S4); (iii) there is an
overrepresentation of ETS transcription factor-like
binding motifs in these clusters; and (iv) there is a signif-
icant overlap in these clusters with direct targets of
GABPa identiﬁed by ChIP-Seq (Supplementary Table
S4). Thus, while we focussed on cluster 3 for validation
purposes, clusters 4, 5 and 8 also represent high conﬁdence
targets for binding by Elk-1 and other ETS transcription
factors, and provide a valuable dataset for others
investigating promoter regulation. Furthermore, genes in
clusters, 3, 4, 5 and 8 showed over-representation of
several functional categories and when considered
together, revealed apoptosis regulation as a new func-
tional category (Supplementary Tables S2 and S3). This
is in keeping with our previous observation that Elk-En
expression promotes apoptosis, in part through repressing
MCL-1 expression (16). The association with apoptosis
regulation appears more speciﬁc to Elk-1 than other
ETS transcription factors as this category was not
identiﬁed previously for genes commonly bound by
Ets-1 and Elf-1, although the other functional categories
7378 Nucleic Acids Research, 2009,Vol.37, No. 22identiﬁed in the current study overlap with subcategories
of the housekeeping genes identiﬁed as commonly bound
by other ETS proteins (13).
It is not clear why we also identiﬁed the genes in clusters
1, 2, 6 and 7 as potentially regulated by Elk-En using this
approach as they seem to not represent direct Elk-1
targets. Indeed, these genes do not contain any over-
represented subcategories. One likely explanation for
their occurrence is that these genes represent indirect
eﬀects whereby Elk-En causes the repression of a gene
that encodes an activator(s) of the genes in these
clusters. However, it is likely that at least some of the
genes in these clusters might well represent direct targets
of ETS transcription factors as clustering analysis is not
deﬁnitive, although clearly further veriﬁcation would be
needed. Indeed, the reciprocal is also true for clusters 3,
4, 5 and 8, which although of high conﬁdence, probably
contain a number of false positives that are not supported
by additional evidence from ChIP-chip data or the
presence of potential binding motifs. Thus in general,
the target genes that are supported by multiple lines of
evidence provide a higher conﬁdence dataset.
In summary, our ﬁndings provide further insights into
target gene selection by members of the ETS-domain tran-
scription factors, highlighting redundancy of binding at
some promoters but highly selective function at others,
dictated by heterotypic interactions with other transcrip-
tion factors. In a broader context, these results have an
impact on framing our understanding of how other multi-
gene families of transcription factors might function
through speciﬁc and redundant promoter recognition.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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